Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:19,20-DiHDPE)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health ng/g tissue
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health ng/g tissue
ST001951 AN003176 Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. Lung Mouse Pulmonary hypertension University of Tokyo ng/mg tissue
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health ng/mL
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health ng/mL
ST000004 AN000004 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS nM
ST000096 AN000152 A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UPLC-QTRAP MS analysis Cultured cells Human Cancer University of California, Davis nM
ST000253 AN000400 NIH WCMC Pilot & Feasibility Project: ?Metabolomics of Neonatal Pulmonary Hypertension? Blood Rat USDA Western Human Nutrition Research Center nM
ST000253 AN000400 NIH WCMC Pilot & Feasibility Project: ?Metabolomics of Neonatal Pulmonary Hypertension? Lung Rat USDA Western Human Nutrition Research Center nM
ST000253 AN000401 NIH WCMC Pilot & Feasibility Project: ?Metabolomics of Neonatal Pulmonary Hypertension? Blood Rat USDA Western Human Nutrition Research Center nM
ST000253 AN000401 NIH WCMC Pilot & Feasibility Project: ?Metabolomics of Neonatal Pulmonary Hypertension? Lung Rat USDA Western Human Nutrition Research Center nM
ST000255 AN000403 NIH WCMC Pilot & Feasibility Project: ?Metabolomics of Neonatal Pulmonary Hypertension? in human Umbilical cord plasma Human Lung disease University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Adipose tissue Mouse University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Blood Mouse University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Brain Mouse University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Liver Mouse University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Muscle Mouse University of California, Davis nM
ST000802 AN001274 Insights into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) phenotypes through comprehensive metabolomics (part III)) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, Davis nM
ST000843 AN001364 Statin Immuno-Metabolomics in Asthma (part I) Lung Rhesus monkey Asthma USDA nM
ST000844 AN001366 Statin Immuno-Metabolomics in Asthma (part II) Blood Rhesus monkey Asthma USDA nM
ST000846 AN001369 Statin Immuno-Metabolomics in Asthma (part IV) Lung Rhesus monkey Asthma USDA nM
ST000872 AN001404 Maternal Hypoxemia and oxidative stress in the fetus, newborn, and adult. exercise training for peripheral artery disease Blood Sheep Oxidative stress USDA nM
ST000873 AN001478 Maternal Hypoxemia and oxidative stress in the fetus, newborn, and adult. exercise training for peripheral artery disease (part II) Adipose tissue Sheep Oxidative stress USDA nM
ST000873 AN001478 Maternal Hypoxemia and oxidative stress in the fetus, newborn, and adult. exercise training for peripheral artery disease (part II) Arteries Sheep Oxidative stress USDA nM
ST000901 AN001467 Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice - Plasma (part V) Blood Mouse Obesity University of California, Davis nM
ST000916 AN001491 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS nM
ST001154 AN001946 A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium Blood Mouse University of California nM
ST001245 AN002069 Luteal lipids regulate progesterone production and may modulate immune cell function during the estrous cycle and pregnancy Corpus Luteum Cow University of California, Davis nM
ST001845 AN002988 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part IV) Blood Human Fatty liver disease University of California, Davis nM
ST002001 AN003264 A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 2) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome Columbia University nM
ST002767 AN004503 Metabolomic analysis of maternal mid-gestation plasma and cord blood: oxylipins Blood Human Autism Columbia University nM
ST002800 AN004556 Hepatic oxylipin profiles in mouse models of Wilson disease: new insights into early hepatic manifestations. Liver Mouse Wilson disease University of California, Davis nM
ST003172 AN005206 Untargeted Metabolomic Profile Of Chili Pepper (Capsicum Chinensed) Developmental Cycle Capsicum Chinense Plant University of Alberta peak area
ST001206 AN002008 Effects of cold exposure on serum lipidomic in mice Blood Mouse Joslin Diabetes Center - Harvard Medical School Peak area
ST001207 AN002009 Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 Blood Mouse Joslin Diabetes Center - Harvard Medical School Peak area
ST001213 AN002024 Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice Blood Mouse Joslin Diabetes Center - Harvard Medical School Peak area
ST001214 AN002025 Lipidommics in the serum of human subjects Blood Human Joslin Diabetes Center - Harvard Medical School Peak area
ST001215 AN002026 Effect of Mirabegron Treatment on serum lipidome Blood Human Joslin Diabetes Center - Harvard Medical School Peak area
ST003394 AN005568 Fatty acid oxygenated metabolites analysis of colon in Pla2g10 knockout mice. Colon Mouse Obesity University of Tokyo Peak area/mg of wet tissue
ST003129 AN005132 Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal liver Liver Mouse University of Copenhagen Peak intensity
ST000452 AN000708 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data Blood Mouse University of North Carolina Peak values (scaled)
ST000902 AN001468 Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice - Liver (part VI) Liver Mouse Obesity University of California, Davis pM
ST000594 AN000910 PGD2 and other lipid mediator changes in mouse adipose associated with administration of an oral inhibitor of H-PGDS (HQL-79) (part II) Adipose tissue Mouse Obesity USDA Western Human Nutrition Research Center pmol/g
ST000598 AN000916 Dysfunctional lipid metabolism underlies the effect of the perinatal DDT exposure on the development of metabolic syndrome (part II) Brain Mouse Metabolic syndrome USDA Western Human Nutrition Research Center pmol/g
ST000659 AN001006 Changes in metabolites and lipid mediators associated with supervised exercise training for peripheral Blood Human Peripheral artery disease USDA Western Human Nutrition Research Center pmol/g
ST000977 AN001598 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) Blood Human Fatty liver disease University of California, Davis pmol/gram
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS pmol/mg
  logo